跳至主要内容
临床试验/NCT01471275
NCT01471275Unknown不适用

The Study of TCM in Prevention and Promote of Community-based Diabetes

Guang'anmen Hospital of China Academy of Chinese Medical Sciences8 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2011年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
450
试验地点
8
主要终点
Glycosylated hemoglobin

研究概览

简要总结

With metformin for the control, evaluate the safety and efficacy of Jiangtangtiaozhi decoction in treatment of obesity with type 2 diabetes, dyslipidemia

详细描述

Waist circumference, body mass index, triglycerides, glycosylated hemoglobin, blood glucose were evaluated; liver function, kidney function, blood, urine, stool, adverse event recording, evaluation of low blood sugar event log security.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • signed informed consent;
  • waistline male ≥ 90cm, female ≥ 80cm;
  • According to the 1999 WHO standards, meet diagnostic criteria for type 2 diabetes onset and untreated patients, after a screening period (diet + exercise therapy 4 weeks) after the fasting plasma glucose ≥ 7.0mmol • L-1, but fasting blood glucose <13.9mmol • L-1, or 2h postprandial blood glucose ≥ 11.1mmol • L-1; and glycated hemoglobin ≥ 7.0%;
  • After a screening period (diet + exercise therapy 4 weeks) after the triglyceride (TG) ≥ 1.7mmol / L, and TG <5.65mmol / L;
  • TCM for the heat of the gastrointestinal;
  • Age 30-65 years old.

排除标准

  • Patients has been used insulin therapy; previously had a continuous period of 3 months or longer treatment of diabetes(including other Chinese and Western medicine, physical therapy, psychological therapy and health food, etc.) ; enrolled within 1 month before the use of blood glucose and lipids drug treatment;
  • Patients with diabetic complications; or a serious heart, lung, liver, kidney, brain and other serious complications or associated with other primary diseases;
  • Patients with uncontrolled blood pressure control, the systolic blood pressure ≥ 160mmHg or (and) diastolic blood pressure ≥ 100mmHg persons;
  • Patients have diabetic ketoacidosis in the last month, diabetic ketoacidosis and severe infections;
  • Patients with mental illness;
  • Pregnancy, pregnancy or breast-feeding women to prepare;
  • Patients with Chinese medicine allergies; and allergy;
  • Patients with had participated in this study within 1 month have participated or are participating in other clinical studies;
  • In the past five years, patients with alcohol and / or psychoactive substances, drug abuse and dependence;
  • According to the researchers to determine, with the possibility of lower income group or the other into a complex set of diseases or conditions, such as work environment, frequent changes in unstable living environment, the situation could easily lead to lost;
  • Patients taking the dose and type of antihypertensive drugs can not remain stable;
  • Patients taking drugs that affect the quality of the body or health food.
  • Patients with liver, impaired renal function (ALT, AST greater than 2 times the upper limit of normal; serum creatinine greater than the upper limit of normal);
  • Patients are known to lower blood sugar for those who are asymptomatic.

研究组 & 干预措施

Jiangtangtiaozhi decoction

Experimental

干预措施: Jiangtangtiaozhi decoction (Drug)

metformin

Active Comparator

干预措施: Metformin (Drug)

结局指标

主要结局

Glycosylated hemoglobin

时间窗: 12 weeks

次要结局

  • Whole blood cell analysis(4 weeks)
  • Urinalysis(12 weeks)
  • Adverse events recorded(4 weeks)
  • Liver function(4 weeks)
  • Renal function(4 weeks)
  • Waistline(4 weeks)
  • Triglycerides(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fengmei Lian

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

研究点 (8)

Loading locations...

相似试验